
No. of Pages: 193 | Report Code: TIPRE00009240 | Category: Life Sciences
No. of Pages: 193 | Report Code: TIPRE00009240 | Category: Life Sciences
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4.1 PEST Analysis
5.1 Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Regulatory Support
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6.1 Europe Genetic Testing Services Market Revenue (US$ Million), 2021–2031
6.2 Europe Genetic Testing Services Market Forecast Analysis
7.1 Predictive Testing
7.1.1 Overview
7.1.2 Predictive Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Carrier Testing
7.2.1 Overview
7.2.2 Carrier Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Prenatal Testing
7.3.1 Overview
7.3.2 Prenatal Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.4 New-born Screening
7.4.1 Overview
7.4.2 New-born Screening: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.5 Diagnostic Genetic Testing
7.5.1 Overview
7.5.2 Diagnostic Genetic Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1 Cancer
8.1.1 Overview
8.1.2 Cancer: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.2 Cardiovascular Diseases
8.2.1 Overview
8.2.2 Cardiovascular Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.3 Metabolic Diseases
8.3.1 Overview
8.3.2 Metabolic Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.4 Other Diseases
8.4.1 Overview
8.4.2 Other Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
9.3 Other End User
9.3.1 Overview
9.3.2 Other End User: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1 Europe
10.1.1 Europe Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Europe Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.1.1.2 United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.2.1 United Kingdom: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.2.2 United Kingdom: Europe Genetic Testing Services Market Share – by Disease
10.1.1.2.3 United Kingdom: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.2.4 United Kingdom: Europe Genetic Testing Services Market Share – by End User
10.1.1.3 Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.3.1 Germany: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.3.2 Germany: Europe Genetic Testing Services Market Share – by Disease
10.1.1.3.3 Germany: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.3.4 Germany: Europe Genetic Testing Services Market Share – by End User
10.1.1.4 France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.4.1 France: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.4.2 France: Europe Genetic Testing Services Market Share – by Disease
10.1.1.4.3 France: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.4.4 France: Europe Genetic Testing Services Market Share – by End User
10.1.1.5 Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.5.1 Spain: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.5.2 Spain: Europe Genetic Testing Services Market Share – by Disease
10.1.1.5.3 Spain: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.5.4 Spain: Europe Genetic Testing Services Market Share – by End User
10.1.1.6 Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.6.1 Italy: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.6.2 Italy: Europe Genetic Testing Services Market Share – by Disease
10.1.1.6.3 Italy: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.6.4 Italy: Europe Genetic Testing Services Market Share – by End User
10.1.1.7 Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.1.1.7.1 Rest of Europe: Europe Genetic Testing Services Market Share – by Service Type
10.1.1.7.2 Rest of Europe: Europe Genetic Testing Services Market Share – by Disease
10.1.1.7.3 Rest of Europe: Europe Genetic Testing Services Market Share – by Cancer Disease
10.1.1.7.4 Rest of Europe: Europe Genetic Testing Services Market Share – by End User
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ancestry Genomics Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Gene By Gene Ltd
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SIVOTEC BioInformatics LLC
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Progenesis
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Fulgent Genetics, Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 VERITAS INTERCONTINENTAL
12.16.1 Business Description
12.16.2 Products and Services
12.16.3 Financial Overview
12.16.4 SWOT Analysis
12.16.5 Key Developments
12.17 GeneDx, LLC
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Europe Genetic Testing Services Market Segmentation
Table 2. Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Type
Table 4. Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease
Table 5. Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by End User
Table 6. Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 7. United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 8. United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 9. United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 10. United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 11. Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 12. Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 13. Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 14. Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 15. France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 16. France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 17. France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 18. France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 19. Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 20. Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 21. Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 22. Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 23. Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 24. Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 25. Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 26. Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 27. Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type
Table 28. Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease
Table 29. Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease
Table 30. Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by End User
Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
Table 33. Glossary of Terms, Genetic Testing Services Market
Figure 1. Europe Genetic Testing Services Market Segmentation – Country
Figure 2. PEST Analysis
Figure 3. Europe Genetic Testing Services Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Genetic Testing Services Market Revenue (US$ Million), 2021–2031
Figure 6. Europe Genetic Testing Services Market Share (%) – by Service Type (2023 and 2031)
Figure 7. Predictive Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Carrier Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Prenatal Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. New-born Screening: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Diagnostic Genetic Testing: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 12. Others: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Europe Genetic Testing Services Market Share (%) – by Disease (2023 and 2031)
Figure 14. Cancer: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 15. Cardiovascular Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 16. Metabolic Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 17. Other Diseases: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 18. Europe Genetic Testing Services Market Share (%) – by End User (2023 and 2031)
Figure 19. Hospital-Based Laboratories: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 20. Diagnostic Laboratories: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 21. Other End User: Europe Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 22. Europe Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. United Kingdom: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 24. Germany: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 25. France: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 26. Spain: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 27. Italy: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 28. Rest of Europe: Europe Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 29. Growth Strategies in Genetic Testing Services Market